Budget Impact Analysis of Gene Therapies for Recessive Dystrophic Epidermolysis Bullosa

Study limitation reported by the research below: “Study design label 'Budget Impact Analysis' is a health economics model, not a clinical trial; level of evidence reflects this accordingly.”